Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Merck
Express Scripts
Medtronic

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Atracurium besylate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for atracurium besylate and what is the scope of freedom to operate?

Atracurium besylate is the generic ingredient in four branded drugs marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hong Kong, Hospira, Hospira Inc, Mylan Labs Ltd, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atracurium besylate. Four suppliers are listed for this compound.

Recent Clinical Trials for atracurium besylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sir Ganga Ram HospitalN/A
Fayoum University HospitalN/A
Mahidol UniversityPhase 4

See all atracurium besylate clinical trials

Pharmacology for atracurium besylate
Medical Subject Heading (MeSH) Categories for atracurium besylate
Synonyms for atracurium besylate
2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester
2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) benzenesulfonate
2,2'-(3,3'-(pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium) benzenesulfonate
2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolinium] Dibenzenesulfonate
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
33 A 74
40AX66P76P
64228-79-1 (Parent)
64228-81-5
A2566
A834680
AB07163
AB1004899
AC1L2HUI
AKOS015895831
AN-15362
AN-6664
AS-14131
Atracurii besilas
Atracurii besilas [INN-Latin]
Atracurium (besylate)
Atracurium besilate
Atracurium besilate (INN)
Atracurium besilate [INN]
Atracurium besylate (USP)
Atracurium besylate [USAN:BAN]
Atracurium besylate [USAN:USP]
Atracurium Besylate Preservative Free
Atracurium besylate, >=98% (HPLC), powder
Atracurium besylate, 96%
Atracurium besylate, European Pharmacopoeia (EP) Reference Standard
Atracurium besylate, mixture of isomers
Atracurium besylate, United States Pharmacopeia (USP) Reference Standard
atracurium dibenzenesulfonate
Atracurium for impurity F identification, European Pharmacopoeia (EP) Reference Standard
Atracurium for peak identification, European Pharmacopoeia (EP) Reference Standard
benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-di
Besilate d'atracurium
Besilate d'atracurium [INN-French]
Besilato de atracurio
Besilato de atracurio [INN-Spanish]
BW 33 A
BW 33A
BW-33A
C53H72N2O12
C65H82N2O18S2
CA0147
CAS-64228-81-5
CCG-213566
CHEBI:2915
CHEMBL1200527
CS-2306
D00758
DB00732
DSSTox_CID_2630
DSSTox_GSID_22630
DSSTox_RID_76665
DTXSID6022630
EINECS 264-743-4
FT-0659516
HMS1568A11
HMS2095A11
HMS3651C21
HMS3712A11
HY-B0292A
hydro-1H-isoquinolin-2-ium-2-yl]propanoate
I06-1457
I14-0811
Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate
K027
KS-00000L5H
LS-176358
MolPort-003-940-284
NC00429
NCGC00017127-01
NCGC00262598-01
NCGC00262598-02
NSC-760047
NSC760047
Pentamethylen bis(3-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-methyl-2-isochinolyl)propionat) bis(benzolsulfonat)
Pharmakon1600-01505872
PubChem3018
Q-101018
Q-200864
SCHEMBL41251
SR-01000781272
SR-01000781272-3
SW197148-4
TL8004537
Tox21_110790
Tracrium
Tracrium (TN)
Tracrium Preservative Free
UNII-40AX66P76P
XXZSQOVSEBAPGS-UHFFFAOYSA-L

US Patents and Regulatory Information for atracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206001-001 Apr 7, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206010-001 Apr 8, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
Teva Parenteral ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074784-001 Jun 11, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Medtronic
McKinsey
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.